IgM Nephropathy After Treatment with Oral 5-Aminosalicylic Acid Derivatives in a Young Patient with Ulcerative Colitis

被引：0
|
作者：
Ho, Edith [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland VA Med Ctr, Cleveland, OH 44106 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-168
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] PREDICTORS OF NONPERSISTENCE AND NONADHERENCE WITH ORAL 5-AMINOSALICYLIC ACID THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
    Yen, L.
    Wu, J.
    Hodgkins, P.
    Nichol, M. B.
    VALUE IN HEALTH, 2012, 15 (04) : A140 - A140
  • [42] Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
    Lee, Jin
    Jee, Sam Ryong
    Kim, Hyung Wook
    Baek, Dong Hoon
    Song, Geun Am
    Moon, Won
    Park, Seun Ja
    Kim, Hyun Jin
    Lee, Jong Hoon
    Park, Jong Ha
    Kim, Tae Oh
    PLOS ONE, 2019, 14 (03):
  • [43] Oral 5-aminosalicylic acid use in ulcerative colitis requiring biological therapy: Is it worth it?
    Bohra, A.
    Koh, E.
    Sandhu, M.
    Ling, S.
    Be, K.
    Lovett, G.
    Romero, S.
    Rajadurai, A.
    Moore, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 145 - 146
  • [44] Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
    Le Berre, Catherine
    Roda, Giulia
    Protic, Marijana Nedeljkovic
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 363 - 378
  • [45] Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis
    Marshall, John K.
    Thabane, Marroon
    Steinhart, A. Hillary
    Newman, Jamie R.
    Anand, Anju
    Irvine, E. Jan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [46] Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
    Marshall, John K.
    Thabane, Marroon
    Steinhart, A. Hillary
    Newman, Jamie R.
    Anand, Anju
    Irvine, E. Jan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [47] 5-AMINOSALICYLIC ACID SUPPOSITORIES IN THE MANAGEMENT OF ULCERATIVE-COLITIS
    CAMPIERI, M
    GIONCHETTI, P
    BELLUZZI, A
    BRIGNOLA, C
    TORRESAN, F
    TAMPIERI, M
    IANNONE, P
    MIGLIOLI, M
    BARBARA, L
    DISEASES OF THE COLON & RECTUM, 1989, 32 (05) : 398 - 399
  • [48] Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis
    Kane, S. V.
    Accortt, N. A.
    Magowan, S.
    Brixner, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (08) : 855 - 862
  • [49] What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
    Riley, SA
    GUT, 1998, 42 (06) : 761 - 763
  • [50] Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis
    Moshkovska, Tetyana
    Stone, Margaret
    Baker, Richard
    Mayberry, John
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (06) : 763 - 768
12345